Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

This publication has 50 references indexed in Scilit:

• Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
  Laboratory Investigation, 2007
• Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
  PLoS Medicine, 2007
• Frequency of theTMPRSS2:ERGgene fusion is increased in moderate to poorly differentiated prostate cancers
  Journal of Clinical Pathology, 2007
• TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor–Negative Prostate Cancer
  Cancer Research, 2006
• Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
  Oncogene, 2006
• TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions
  Neoplasia, 2006
• Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement
  Neoplasia, 2006
• Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual Disease
  Cell Cycle, 2006
• Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
  Science, 2005
• Pathological and molecular aspects of prostate cancer
  The Lancet, 2003